CELL MOL LIFE SCI 润色咨询

CELLULAR AND MOLECULAR LIFE SCIENCES

出版年份:1997 年文章数:4705 投稿命中率: 开通期刊会员,数据随心看

出版周期:Semimonthly 自引率:1.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2023.9.26 Submitted to journal<br>2023.9.30 With Editor<br>2023.10.3 Under review<br>2023.11.3 Required reviews completed<br>2023.11.13 Major revision<br>2023.12.25 Revision submitted to journal<br>2023.12.26 With Editor<br>2023.12.26 Under review<br>2023.12.27 Required reviews completed<br>2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事,投稿近一个月还是with editor,转OA了变慢了吗?我想三月份见刊,还有没有戏,等多久催编辑部呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:CMLS是欧洲老牌期刊,对研究型论文要求很高,缺乏创新和深度的文章一般连外审的机会都没有!至于综述,通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;肿瘤;分子机制<br>经验分享:欧洲老牌杂志,三天内with editor, 十天内Under review, 一个月内Minor revision,要求文章创新性比较高,数据全面且研究深入,审稿人意见比较专业,提了许多比较细的问题,总的来说还是比较难投,感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家,这个杂志有几个reviewer<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:等了一个月,编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156868, encodeId=2372215686814, content=1. 2023.06.19 投稿 6.20号收到邮件因格式问题返回 6.21号重新投稿 <br>2. 2023.06.22 with editor<br>3. 2023.07.13 送审<br>4. 2023.07.30 审稿意见返回编辑部 (外审用了17天,不到3周)<br>5. 2023.08.02 收到审稿意见(大修)<br>6. 2023.08.23 返修<br>7. 2023.09.01 第二轮审稿<br>目前20230909 还在继续等待<br>这个期刊挺不错的,定位也蛮好,明年转为OA,希望影响因子节节攀升!<br>希望审稿人和编辑身体健康,万事顺心!<br>对你有帮助的话麻烦点个赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230909/ab7ced1ee00e4b7293853018393bfefa/401f3842f3034101be5a5b7e2849e373.jpg, createdBy=0b845546395, createdName=ms9000000447204416, createdTime=Sat Sep 09 14:11:37 CST 2023, time=2023-09-09, status=1, ipAttribution=阿姆斯特丹), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向:细胞生物学<br>经验分享:这个杂志一开始看评论很快,大概七月底投得,with editor三周,可是under review将近三个月了还是under review,这是怎么了,急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京)]
    2023-12-28 ms5000000204318340 来自山东省

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:2023.9.26 Submitted to journal
    2023.9.30 With Editor
    2023.10.3 Under review
    2023.11.3 Required reviews completed
    2023.11.13 Major revision
    2023.12.25 Revision submitted to journal
    2023.12.26 With Editor
    2023.12.26 Under review
    2023.12.27 Required reviews completed
    2023.12.27 Accept

    6

    展开6条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2023.9.26 Submitted to journal<br>2023.9.30 With Editor<br>2023.10.3 Under review<br>2023.11.3 Required reviews completed<br>2023.11.13 Major revision<br>2023.12.25 Revision submitted to journal<br>2023.12.26 With Editor<br>2023.12.26 Under review<br>2023.12.27 Required reviews completed<br>2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事,投稿近一个月还是with editor,转OA了变慢了吗?我想三月份见刊,还有没有戏,等多久催编辑部呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:CMLS是欧洲老牌期刊,对研究型论文要求很高,缺乏创新和深度的文章一般连外审的机会都没有!至于综述,通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;肿瘤;分子机制<br>经验分享:欧洲老牌杂志,三天内with editor, 十天内Under review, 一个月内Minor revision,要求文章创新性比较高,数据全面且研究深入,审稿人意见比较专业,提了许多比较细的问题,总的来说还是比较难投,感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家,这个杂志有几个reviewer<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:等了一个月,编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156868, encodeId=2372215686814, content=1. 2023.06.19 投稿 6.20号收到邮件因格式问题返回 6.21号重新投稿 <br>2. 2023.06.22 with editor<br>3. 2023.07.13 送审<br>4. 2023.07.30 审稿意见返回编辑部 (外审用了17天,不到3周)<br>5. 2023.08.02 收到审稿意见(大修)<br>6. 2023.08.23 返修<br>7. 2023.09.01 第二轮审稿<br>目前20230909 还在继续等待<br>这个期刊挺不错的,定位也蛮好,明年转为OA,希望影响因子节节攀升!<br>希望审稿人和编辑身体健康,万事顺心!<br>对你有帮助的话麻烦点个赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230909/ab7ced1ee00e4b7293853018393bfefa/401f3842f3034101be5a5b7e2849e373.jpg, createdBy=0b845546395, createdName=ms9000000447204416, createdTime=Sat Sep 09 14:11:37 CST 2023, time=2023-09-09, status=1, ipAttribution=阿姆斯特丹), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向:细胞生物学<br>经验分享:这个杂志一开始看评论很快,大概七月底投得,with editor三周,可是under review将近三个月了还是under review,这是怎么了,急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京)]
    2023-10-16 科研小麻瓜 来自广东省

    这个杂志是怎么回事,投稿近一个月还是with editor,转OA了变慢了吗?我想三月份见刊,还有没有戏,等多久催编辑部呀?

    20

    展开20条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2023.9.26 Submitted to journal<br>2023.9.30 With Editor<br>2023.10.3 Under review<br>2023.11.3 Required reviews completed<br>2023.11.13 Major revision<br>2023.12.25 Revision submitted to journal<br>2023.12.26 With Editor<br>2023.12.26 Under review<br>2023.12.27 Required reviews completed<br>2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事,投稿近一个月还是with editor,转OA了变慢了吗?我想三月份见刊,还有没有戏,等多久催编辑部呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:CMLS是欧洲老牌期刊,对研究型论文要求很高,缺乏创新和深度的文章一般连外审的机会都没有!至于综述,通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;肿瘤;分子机制<br>经验分享:欧洲老牌杂志,三天内with editor, 十天内Under review, 一个月内Minor revision,要求文章创新性比较高,数据全面且研究深入,审稿人意见比较专业,提了许多比较细的问题,总的来说还是比较难投,感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家,这个杂志有几个reviewer<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:等了一个月,编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156868, encodeId=2372215686814, content=1. 2023.06.19 投稿 6.20号收到邮件因格式问题返回 6.21号重新投稿 <br>2. 2023.06.22 with editor<br>3. 2023.07.13 送审<br>4. 2023.07.30 审稿意见返回编辑部 (外审用了17天,不到3周)<br>5. 2023.08.02 收到审稿意见(大修)<br>6. 2023.08.23 返修<br>7. 2023.09.01 第二轮审稿<br>目前20230909 还在继续等待<br>这个期刊挺不错的,定位也蛮好,明年转为OA,希望影响因子节节攀升!<br>希望审稿人和编辑身体健康,万事顺心!<br>对你有帮助的话麻烦点个赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230909/ab7ced1ee00e4b7293853018393bfefa/401f3842f3034101be5a5b7e2849e373.jpg, createdBy=0b845546395, createdName=ms9000000447204416, createdTime=Sat Sep 09 14:11:37 CST 2023, time=2023-09-09, status=1, ipAttribution=阿姆斯特丹), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向:细胞生物学<br>经验分享:这个杂志一开始看评论很快,大概七月底投得,with editor三周,可是under review将近三个月了还是under review,这是怎么了,急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京)]
    2021-11-16 山蛙

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享:CMLS是欧洲老牌期刊,对研究型论文要求很高,缺乏创新和深度的文章一般连外审的机会都没有!至于综述,通讯作者的研究履历是一个重要机会。

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2023.9.26 Submitted to journal<br>2023.9.30 With Editor<br>2023.10.3 Under review<br>2023.11.3 Required reviews completed<br>2023.11.13 Major revision<br>2023.12.25 Revision submitted to journal<br>2023.12.26 With Editor<br>2023.12.26 Under review<br>2023.12.27 Required reviews completed<br>2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事,投稿近一个月还是with editor,转OA了变慢了吗?我想三月份见刊,还有没有戏,等多久催编辑部呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:CMLS是欧洲老牌期刊,对研究型论文要求很高,缺乏创新和深度的文章一般连外审的机会都没有!至于综述,通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;肿瘤;分子机制<br>经验分享:欧洲老牌杂志,三天内with editor, 十天内Under review, 一个月内Minor revision,要求文章创新性比较高,数据全面且研究深入,审稿人意见比较专业,提了许多比较细的问题,总的来说还是比较难投,感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家,这个杂志有几个reviewer<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:等了一个月,编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156868, encodeId=2372215686814, content=1. 2023.06.19 投稿 6.20号收到邮件因格式问题返回 6.21号重新投稿 <br>2. 2023.06.22 with editor<br>3. 2023.07.13 送审<br>4. 2023.07.30 审稿意见返回编辑部 (外审用了17天,不到3周)<br>5. 2023.08.02 收到审稿意见(大修)<br>6. 2023.08.23 返修<br>7. 2023.09.01 第二轮审稿<br>目前20230909 还在继续等待<br>这个期刊挺不错的,定位也蛮好,明年转为OA,希望影响因子节节攀升!<br>希望审稿人和编辑身体健康,万事顺心!<br>对你有帮助的话麻烦点个赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230909/ab7ced1ee00e4b7293853018393bfefa/401f3842f3034101be5a5b7e2849e373.jpg, createdBy=0b845546395, createdName=ms9000000447204416, createdTime=Sat Sep 09 14:11:37 CST 2023, time=2023-09-09, status=1, ipAttribution=阿姆斯特丹), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向:细胞生物学<br>经验分享:这个杂志一开始看评论很快,大概七月底投得,with editor三周,可是under review将近三个月了还是under review,这是怎么了,急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京)]
    2022-08-09 ms2000000705029865

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:分子生物学;肿瘤;分子机制
    经验分享:欧洲老牌杂志,三天内with editor, 十天内Under review, 一个月内Minor revision,要求文章创新性比较高,数据全面且研究深入,审稿人意见比较专业,提了许多比较细的问题,总的来说还是比较难投,感觉对国人还算友好

    5

    展开5条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2023.9.26 Submitted to journal<br>2023.9.30 With Editor<br>2023.10.3 Under review<br>2023.11.3 Required reviews completed<br>2023.11.13 Major revision<br>2023.12.25 Revision submitted to journal<br>2023.12.26 With Editor<br>2023.12.26 Under review<br>2023.12.27 Required reviews completed<br>2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事,投稿近一个月还是with editor,转OA了变慢了吗?我想三月份见刊,还有没有戏,等多久催编辑部呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:CMLS是欧洲老牌期刊,对研究型论文要求很高,缺乏创新和深度的文章一般连外审的机会都没有!至于综述,通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;肿瘤;分子机制<br>经验分享:欧洲老牌杂志,三天内with editor, 十天内Under review, 一个月内Minor revision,要求文章创新性比较高,数据全面且研究深入,审稿人意见比较专业,提了许多比较细的问题,总的来说还是比较难投,感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家,这个杂志有几个reviewer<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:等了一个月,编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156868, encodeId=2372215686814, content=1. 2023.06.19 投稿 6.20号收到邮件因格式问题返回 6.21号重新投稿 <br>2. 2023.06.22 with editor<br>3. 2023.07.13 送审<br>4. 2023.07.30 审稿意见返回编辑部 (外审用了17天,不到3周)<br>5. 2023.08.02 收到审稿意见(大修)<br>6. 2023.08.23 返修<br>7. 2023.09.01 第二轮审稿<br>目前20230909 还在继续等待<br>这个期刊挺不错的,定位也蛮好,明年转为OA,希望影响因子节节攀升!<br>希望审稿人和编辑身体健康,万事顺心!<br>对你有帮助的话麻烦点个赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230909/ab7ced1ee00e4b7293853018393bfefa/401f3842f3034101be5a5b7e2849e373.jpg, createdBy=0b845546395, createdName=ms9000000447204416, createdTime=Sat Sep 09 14:11:37 CST 2023, time=2023-09-09, status=1, ipAttribution=阿姆斯特丹), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向:细胞生物学<br>经验分享:这个杂志一开始看评论很快,大概七月底投得,with editor三周,可是under review将近三个月了还是under review,这是怎么了,急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京)]
    2024-02-26 ms4000000389646164 来自浙江省

    no

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2023.9.26 Submitted to journal<br>2023.9.30 With Editor<br>2023.10.3 Under review<br>2023.11.3 Required reviews completed<br>2023.11.13 Major revision<br>2023.12.25 Revision submitted to journal<br>2023.12.26 With Editor<br>2023.12.26 Under review<br>2023.12.27 Required reviews completed<br>2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事,投稿近一个月还是with editor,转OA了变慢了吗?我想三月份见刊,还有没有戏,等多久催编辑部呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:CMLS是欧洲老牌期刊,对研究型论文要求很高,缺乏创新和深度的文章一般连外审的机会都没有!至于综述,通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;肿瘤;分子机制<br>经验分享:欧洲老牌杂志,三天内with editor, 十天内Under review, 一个月内Minor revision,要求文章创新性比较高,数据全面且研究深入,审稿人意见比较专业,提了许多比较细的问题,总的来说还是比较难投,感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家,这个杂志有几个reviewer<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:等了一个月,编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156868, encodeId=2372215686814, content=1. 2023.06.19 投稿 6.20号收到邮件因格式问题返回 6.21号重新投稿 <br>2. 2023.06.22 with editor<br>3. 2023.07.13 送审<br>4. 2023.07.30 审稿意见返回编辑部 (外审用了17天,不到3周)<br>5. 2023.08.02 收到审稿意见(大修)<br>6. 2023.08.23 返修<br>7. 2023.09.01 第二轮审稿<br>目前20230909 还在继续等待<br>这个期刊挺不错的,定位也蛮好,明年转为OA,希望影响因子节节攀升!<br>希望审稿人和编辑身体健康,万事顺心!<br>对你有帮助的话麻烦点个赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230909/ab7ced1ee00e4b7293853018393bfefa/401f3842f3034101be5a5b7e2849e373.jpg, createdBy=0b845546395, createdName=ms9000000447204416, createdTime=Sat Sep 09 14:11:37 CST 2023, time=2023-09-09, status=1, ipAttribution=阿姆斯特丹), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向:细胞生物学<br>经验分享:这个杂志一开始看评论很快,大概七月底投得,with editor三周,可是under review将近三个月了还是under review,这是怎么了,急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京)]
    2024-02-26 ms4000000389646164 来自浙江省

    no

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2023.9.26 Submitted to journal<br>2023.9.30 With Editor<br>2023.10.3 Under review<br>2023.11.3 Required reviews completed<br>2023.11.13 Major revision<br>2023.12.25 Revision submitted to journal<br>2023.12.26 With Editor<br>2023.12.26 Under review<br>2023.12.27 Required reviews completed<br>2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事,投稿近一个月还是with editor,转OA了变慢了吗?我想三月份见刊,还有没有戏,等多久催编辑部呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:CMLS是欧洲老牌期刊,对研究型论文要求很高,缺乏创新和深度的文章一般连外审的机会都没有!至于综述,通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;肿瘤;分子机制<br>经验分享:欧洲老牌杂志,三天内with editor, 十天内Under review, 一个月内Minor revision,要求文章创新性比较高,数据全面且研究深入,审稿人意见比较专业,提了许多比较细的问题,总的来说还是比较难投,感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家,这个杂志有几个reviewer<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:等了一个月,编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156868, encodeId=2372215686814, content=1. 2023.06.19 投稿 6.20号收到邮件因格式问题返回 6.21号重新投稿 <br>2. 2023.06.22 with editor<br>3. 2023.07.13 送审<br>4. 2023.07.30 审稿意见返回编辑部 (外审用了17天,不到3周)<br>5. 2023.08.02 收到审稿意见(大修)<br>6. 2023.08.23 返修<br>7. 2023.09.01 第二轮审稿<br>目前20230909 还在继续等待<br>这个期刊挺不错的,定位也蛮好,明年转为OA,希望影响因子节节攀升!<br>希望审稿人和编辑身体健康,万事顺心!<br>对你有帮助的话麻烦点个赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230909/ab7ced1ee00e4b7293853018393bfefa/401f3842f3034101be5a5b7e2849e373.jpg, createdBy=0b845546395, createdName=ms9000000447204416, createdTime=Sat Sep 09 14:11:37 CST 2023, time=2023-09-09, status=1, ipAttribution=阿姆斯特丹), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向:细胞生物学<br>经验分享:这个杂志一开始看评论很快,大概七月底投得,with editor三周,可是under review将近三个月了还是under review,这是怎么了,急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京)]
    2024-02-20 ms2000000711984129 来自广东省

    请问大家,这个杂志有几个reviewer

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2023.9.26 Submitted to journal<br>2023.9.30 With Editor<br>2023.10.3 Under review<br>2023.11.3 Required reviews completed<br>2023.11.13 Major revision<br>2023.12.25 Revision submitted to journal<br>2023.12.26 With Editor<br>2023.12.26 Under review<br>2023.12.27 Required reviews completed<br>2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事,投稿近一个月还是with editor,转OA了变慢了吗?我想三月份见刊,还有没有戏,等多久催编辑部呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:CMLS是欧洲老牌期刊,对研究型论文要求很高,缺乏创新和深度的文章一般连外审的机会都没有!至于综述,通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;肿瘤;分子机制<br>经验分享:欧洲老牌杂志,三天内with editor, 十天内Under review, 一个月内Minor revision,要求文章创新性比较高,数据全面且研究深入,审稿人意见比较专业,提了许多比较细的问题,总的来说还是比较难投,感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家,这个杂志有几个reviewer<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:等了一个月,编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156868, encodeId=2372215686814, content=1. 2023.06.19 投稿 6.20号收到邮件因格式问题返回 6.21号重新投稿 <br>2. 2023.06.22 with editor<br>3. 2023.07.13 送审<br>4. 2023.07.30 审稿意见返回编辑部 (外审用了17天,不到3周)<br>5. 2023.08.02 收到审稿意见(大修)<br>6. 2023.08.23 返修<br>7. 2023.09.01 第二轮审稿<br>目前20230909 还在继续等待<br>这个期刊挺不错的,定位也蛮好,明年转为OA,希望影响因子节节攀升!<br>希望审稿人和编辑身体健康,万事顺心!<br>对你有帮助的话麻烦点个赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230909/ab7ced1ee00e4b7293853018393bfefa/401f3842f3034101be5a5b7e2849e373.jpg, createdBy=0b845546395, createdName=ms9000000447204416, createdTime=Sat Sep 09 14:11:37 CST 2023, time=2023-09-09, status=1, ipAttribution=阿姆斯特丹), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向:细胞生物学<br>经验分享:这个杂志一开始看评论很快,大概七月底投得,with editor三周,可是under review将近三个月了还是under review,这是怎么了,急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京)]
    2022-11-18 33333333

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤
    经验分享:等了一个月,编辑说没找到审稿人........这杂志是不是不太行

    5

    展开5条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2023.9.26 Submitted to journal<br>2023.9.30 With Editor<br>2023.10.3 Under review<br>2023.11.3 Required reviews completed<br>2023.11.13 Major revision<br>2023.12.25 Revision submitted to journal<br>2023.12.26 With Editor<br>2023.12.26 Under review<br>2023.12.27 Required reviews completed<br>2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事,投稿近一个月还是with editor,转OA了变慢了吗?我想三月份见刊,还有没有戏,等多久催编辑部呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:CMLS是欧洲老牌期刊,对研究型论文要求很高,缺乏创新和深度的文章一般连外审的机会都没有!至于综述,通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;肿瘤;分子机制<br>经验分享:欧洲老牌杂志,三天内with editor, 十天内Under review, 一个月内Minor revision,要求文章创新性比较高,数据全面且研究深入,审稿人意见比较专业,提了许多比较细的问题,总的来说还是比较难投,感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家,这个杂志有几个reviewer<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:等了一个月,编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156868, encodeId=2372215686814, content=1. 2023.06.19 投稿 6.20号收到邮件因格式问题返回 6.21号重新投稿 <br>2. 2023.06.22 with editor<br>3. 2023.07.13 送审<br>4. 2023.07.30 审稿意见返回编辑部 (外审用了17天,不到3周)<br>5. 2023.08.02 收到审稿意见(大修)<br>6. 2023.08.23 返修<br>7. 2023.09.01 第二轮审稿<br>目前20230909 还在继续等待<br>这个期刊挺不错的,定位也蛮好,明年转为OA,希望影响因子节节攀升!<br>希望审稿人和编辑身体健康,万事顺心!<br>对你有帮助的话麻烦点个赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230909/ab7ced1ee00e4b7293853018393bfefa/401f3842f3034101be5a5b7e2849e373.jpg, createdBy=0b845546395, createdName=ms9000000447204416, createdTime=Sat Sep 09 14:11:37 CST 2023, time=2023-09-09, status=1, ipAttribution=阿姆斯特丹), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向:细胞生物学<br>经验分享:这个杂志一开始看评论很快,大概七月底投得,with editor三周,可是under review将近三个月了还是under review,这是怎么了,急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京)]
    2023-09-09 ms9000000447204416 来自阿姆斯特丹

    1. 2023.06.19 投稿 6.20号收到邮件因格式问题返回 6.21号重新投稿
    2. 2023.06.22 with editor
    3. 2023.07.13 送审
    4. 2023.07.30 审稿意见返回编辑部 (外审用了17天,不到3周)
    5. 2023.08.02 收到审稿意见(大修)
    6. 2023.08.23 返修
    7. 2023.09.01 第二轮审稿
    目前20230909 还在继续等待
    这个期刊挺不错的,定位也蛮好,明年转为OA,希望影响因子节节攀升!
    希望审稿人和编辑身体健康,万事顺心!
    对你有帮助的话麻烦点个赞。

    8

    展开8条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2023.9.26 Submitted to journal<br>2023.9.30 With Editor<br>2023.10.3 Under review<br>2023.11.3 Required reviews completed<br>2023.11.13 Major revision<br>2023.12.25 Revision submitted to journal<br>2023.12.26 With Editor<br>2023.12.26 Under review<br>2023.12.27 Required reviews completed<br>2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事,投稿近一个月还是with editor,转OA了变慢了吗?我想三月份见刊,还有没有戏,等多久催编辑部呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:CMLS是欧洲老牌期刊,对研究型论文要求很高,缺乏创新和深度的文章一般连外审的机会都没有!至于综述,通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;肿瘤;分子机制<br>经验分享:欧洲老牌杂志,三天内with editor, 十天内Under review, 一个月内Minor revision,要求文章创新性比较高,数据全面且研究深入,审稿人意见比较专业,提了许多比较细的问题,总的来说还是比较难投,感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2189423, encodeId=3331218942342, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:31:22 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189422, encodeId=8f662189422c1, content=no, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e838161588, createdName=ms4000000389646164, createdTime=Mon Feb 26 11:30:58 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2188268, encodeId=fb5d2188268e4, content=请问大家,这个杂志有几个reviewer<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53008499251, createdName=ms2000000711984129, createdTime=Tue Feb 20 10:33:54 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:等了一个月,编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156868, encodeId=2372215686814, content=1. 2023.06.19 投稿 6.20号收到邮件因格式问题返回 6.21号重新投稿 <br>2. 2023.06.22 with editor<br>3. 2023.07.13 送审<br>4. 2023.07.30 审稿意见返回编辑部 (外审用了17天,不到3周)<br>5. 2023.08.02 收到审稿意见(大修)<br>6. 2023.08.23 返修<br>7. 2023.09.01 第二轮审稿<br>目前20230909 还在继续等待<br>这个期刊挺不错的,定位也蛮好,明年转为OA,希望影响因子节节攀升!<br>希望审稿人和编辑身体健康,万事顺心!<br>对你有帮助的话麻烦点个赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230909/ab7ced1ee00e4b7293853018393bfefa/401f3842f3034101be5a5b7e2849e373.jpg, createdBy=0b845546395, createdName=ms9000000447204416, createdTime=Sat Sep 09 14:11:37 CST 2023, time=2023-09-09, status=1, ipAttribution=阿姆斯特丹), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向:细胞生物学<br>经验分享:这个杂志一开始看评论很快,大概七月底投得,with editor三周,可是under review将近三个月了还是under review,这是怎么了,急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京)]
    2023-11-09 默默0606 来自北京

    偏重的研究方向:细胞生物学
    经验分享:这个杂志一开始看评论很快,大概七月底投得,with editor三周,可是under review将近三个月了还是under review,这是怎么了,急啊。不知道还要多久……

    8

    展开8条回复
共239条页码: 1/24页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分